IMPLEMENTATION OF PHARMACIST ANTIMICROBIAL STEWARDSHIP
INTERVENTION AT DISCHARGE MEDICATION RECONCILIATION REVIEW
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BACKGROUND

Antimicrobial stewardship is an essential part of
pharmacist practice to ensure that patients on
antimicrobials have appropriate selection, dosing,
and duration based on indication and other
patient-specific factors.1
✓ Most hospital stewardship programs focus on
inpatient antibiotic prescribing; however, most
patients complete their antibiotic course in the
outpatient setting.
✓ This points out a practice deficit, in that there is
limited pharmacist interventions made for outpatient
prescribing compared to inpatient.
Previous studies have indicated that more than
half of all patients discharged on antibiotics
have.2
✓ Inappropriate spectrum of activity
✓ Incorrect dosing
✓ Extended durations
✓ No clinical indication
Current Literature
Conner et al.3
✓ Multicenter, retrospective review
✓ Adult patients discharged on continuation of
antimicrobial therapy for the following indications:
SSTI, UTI, CAP, COPD
✓ Primary outcome was to evaluate durations of
therapy:
✓ SSTI 5-7 days
✓ Uncomplicated UTI 3-5 days
✓ CAP 5 days
✓ COPD 3-5 days
✓ Most used antibiotics: beta-lactams
✓ Finding: For uncomplicated UTI and SSTI, median
durations extended beyond recommended durations.
Pharmacists can help play an essential role in
discharge medication reconciliation to help
ensure:
✓ Appropriateness of antimicrobials utilized for
pathogen/indication as well as dosing based on
patient-specific factors and appropriate IV to PO
stepdown
✓ Prevention of antibiotic-related adverse events
✓ Optimization of stewardship practices

STUDY OBJECTIVES
The main objective of this study is to evaluate 30-day
readmission rates, appropriateness of antimicrobial
prescriptions, and treatment failure/adverse events
within the discharge medication reconciliation review
process.

METHODS

RESULTS

Study Design
✓ Single-center IRB-approved, observational, quality
improvement review

Control

Intervention

Timeframe:
July 2021 – October 2021

Timeframe:
December 2021 – March 2022
Practice:
Practice:
✓Site-specific PGY2 Infectious
✓No standardized practice for
Disease Resident evaluated
pharmacist to evaluate
medication reconciliation at
medication reconciliation at
discharge for appropriateness
discharge for appropriateness
of outpatient antimicrobials
of outpatient antimicrobials.
✓Data Sourced: Discharge
order notifications in Epic
✓Data Sourced → AAH
electronic medical health
“In-Basket” messages
records via monthly discharge
medication order reports
✓Data collection: prospective,
(July 2021-October 2021)
real-time
✓Data collection:
retrospective
Patient Population
✓ Adult patients > 18 years of age were included if they
were discharged on enteral antibiotics during study
timeframe with documented non-life-threatening
infections including but not limited to: soft skin and
tissues infection, urinary tract infection,
pneumonia/respiratory infections, intra-abdominal
infections.
Study Endpoints
✓ Primary
✓ 30-day readmission rates for persistent or
worsening of infectious symptoms OR for
antibiotic-related adverse effect (excluding hospital
readmissions or ER visits unrelated to infectious
disease)
✓ Secondary
✓ Assessment of antimicrobial regimen: antimicrobial
selection, dose, and duration in relation to
infectious indication and required spectrum of
activity
✓ Treatment failure AND/OR treatment-associated
adverse events
Statistical Analysis
✓ Unpaired T-test: continuous data
✓ Fisher’s exact test: categorical data

DICUSSION

Control Period

Intervention Period

366 total patients
screened

197 total patient
screened

• 50 patients selected
to meet inclusion
criteria

• 50 patients met
inclusion criteria

Baseline Characteristics
✓ Mean age (years): 44 years in control group vs 40
years in intervention group
✓ Mean baseline serum creatinine: 0.79 ug/ml in
control group vs 0.81 ug/ml in intervention group
✓ Most common antibiotic indications:
✓ UTI/genitourinary
✓ SSTI
✓ Pulmonary
✓ Most common antibiotic class prescribed on
discharge:
✓ Beta-lactams
Primary Outcome:
Control,
n=50
30-day IDrelated
admission
rate – no
(%)

3 (6)

Intervention,
n=50

P-Value

2 (4)

0.646

Control, n=3

ID-related
inpatient
readmissions

• SSTI – worsening
appearance,
purulence,
erythema (2)
• HAP –
symptomatic
worsening (1)
Intervention,
n=2

• CDI Relapse (1)
• UTI symptom
worsening (1).
Secondary Outcomes
✓ Inappropriate orders: 22% in control vs 14% in
intervention group.
✓ Majority of inappropriate orders were related to
duration of therapy, antimicrobial selection, or dose.
✓ In the intervention group, 6% of total interventions
made were accepted.

Strengths
✓ Relevant clinical question (targeting transitions of
care)
✓ Diverse patient population
Limitations
✓ Small sample size (only 100 patients total)
✓ Different methods of data collection
✓ Prospective vs retrospective → introduces selection
bias
✓ Workflow barriers → single pharmacist

CONCLUSIONS
The impact of one single pharmacist (not
dedicated to floor/unit-specific care) was unable
to show a clinical or statistical significance
compared to no pharmacist intervention.
✓ This may be misrepresented due to the low sample
size that was surveyed in this study.
✓ Creating a standardized model where ALL inpatient
pharmacists perform discharge medication
reconciliation duties may make the minuscule results
of this study seem much more significant.
Additional Findings:
✓ Inappropriate antibiotic orders at discharge: 14%
intervention vs 22% control.
✓ Compared to AAH system recommendations, the
antimicrobial durations of therapy exceeded by 1-3
days in the control group and 1-4 days in the
intervention group.
Future Directions
✓ New model to be implemented at Advocate Christ
Medical Center, with hopes that a team of
pharmacists working together for this initiative will
yield better patient outcomes than one single
pharmacist. This is inspired from current practice at a
sister-hospital which has shown successful results.
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